MOOD — Lucy Scientific Discovery Income Statement
0.000.00%
Last trade - 00:00
- CA$1.58m
- CA$0.47m
- CA$0.04m
- 64
- 21
- 26
- 30
2020 June 30th | 2021 June 30th | 2022 June 30th | 2023 June 30th | |
---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M |
Source: | PROSPECTUS | PROSPECTUS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final |
Revenue | ||||
Total Revenue | 0 | 0 | 0.016 | 0.043 |
Cost of Revenue | ||||
Gross Profit | — | — | -0.148 | 0.041 |
Selling / General / Administrative Expenses | ||||
Depreciation and Amortization | ||||
Unusual Expense / Income | ||||
Other Operating Expenses | ||||
Total Operating Expenses | 0.432 | 1.56 | 1.88 | 0.864 |
Operating Profit | -0.432 | -1.56 | -1.87 | -0.821 |
Gain / Loss on Sale of Assets | ||||
Total Net Non Operating Interest Income / Expense | ||||
Other Net Non Operating Costs | ||||
Net Income Before Taxes | -0.432 | -1.63 | -1.94 | -1.78 |
Net Income After Taxes | -0.432 | -1.63 | -1.94 | -1.78 |
Net Income Before Extraordinary Items | ||||
Net Income | -0.432 | -1.63 | -1.94 | -1.78 |
Income Available to Common Shareholders Excluding Extraordinary Items | ||||
Income Available to Common Shareholders Including Extraordinary Items | ||||
Diluted Net Income | -0.432 | -1.63 | -1.94 | -1.78 |
Diluted Weighted Average Shares | ||||
Basic EPS Including Extraordinary Items | ||||
Diluted EPS Including Extraordinary Items | ||||
Diluted EPS Excluding Extraordinary Items | ||||
Normalised Income Before Taxes | ||||
Normalised Income After Taxes | ||||
Normalised Income Available to Common Shareholders | ||||
Diluted Normalised EPS | -0.123 | -0.442 | -0.482 | -0.398 |